LAMICTAL        SUPPORTING DATA 
Prevents depression
Does not destabilize mood
Improves quality of life
Tolerability similar to placebo
No weight gain
Supporting data
13 years of experience
A new approach
Introduce at any phase
Can be used in combination
Supported by GSK.
(c) 2004 Excerpta Medica
All rights reserved.
Disclaimer
print this page
 Lamotrigine and changes in body weight*

Authors: Calabrese J, et al.
Title: Effects of lithium and lamotrigine on body weight after 18 months in bipolar I disorder.
Reference: European Neuropsychopharmacology, The Journal of the European College of Neuropsychopharmacology 2003;3(Suppl 4):S265.
Purpose: To examine the effects of lithium and lamotrigine on body weight.
Study design: Secondary analysis of two randomized, double-blinded trials.
Follow up: 18 months.
Patients: 638 patients (280 lamotrigine, 167 lithium).
Treatment: Lamotrigine 50–400 mg/day, lithium 0.18–1.1 mEq.
Results: Changes in patient body weight were significantly smaller in the lamotrigine-treatment group compared with patients in either the placebo- or lithium-treatment group. This difference was most evident in the obese category of patients, where on average, weight gain was +1.46 kg with placebo, +3.3 kg with lithium, and –2.96kg with lamotrigine.

*Sponsored by GSK



 
 


 
home help sitemap acronyms help sitemap home